GLP-1 RAs may significantly increase the risk of neovascular age-related macular degeneration in older adults with diabetes.

The layoffs will heavily affect Vertex’s operations in Rhode Island, where the biotech will consolidate three facilities into ...

T1D Exchange, a nonprofit organization that drives meaningful research and improvement in care and outcomes in type 1 ...

WEDNESDAY, June 11, 2025 (HealthDay News) — Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and ...

Abbott is cranking up the innovation dial with a new partnership alongside Tandem Diabetes, aiming to reshape diabetes ...

GLP-1 RA use was linked to a 2.21-fold risk of developing neovascular age-related macular degeneration// (nAMD) * Only 0.2% ...

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite ...

An estimated 38.1 million adults in the United States had diagnosed diabetes in 2021, according to the Centers for Disease ...

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

During a session at the Heart in Diabetes CME Conference, speakers highlighted four papers recently published in Circulation ...